![](/img/cover-not-exists.png)
Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens
J.Z. Appel, M.G. Hartwig, E. Cantu, S.M. Palmer, N.L. Reinsmoen, R.D. DavisVolume:
24
Year:
2005
Language:
english
DOI:
10.1016/j.healun.2004.11.178
File:
PDF, 64 KB
english, 2005